Search results

• 2012

  Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

  Wilkie, S., van Schalkwyk, M. C. I., Hobbs, S., Davies, D. M., van der Stegen, S. J. C., Pereira, A. C. P., Burbridge, S. E., Box, C., Eccles, S. A. & Maher, J., Oct 2012, In: Journal of Clinical Immunology. 32, 5, p. 1059-1070 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Cancer 100%
  • Mucin 1 100%
  • Chimeric Antigen Receptor 100%
  • T Cell 80%
  • Peptide 20%
  404 Citations (Scopus)

• Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells

  Davies, D. M., Foster, J., Van Der Stegen, S. J. C., Parente-Pereira, A. C., Chiapero-Stanke, L., Delinassios, G. J., Burbridge, S. E., Kao, V., Liu, Z., Bosshard-Carter, L., Van Schalkwyk, M. C. I., Box, C., Eccles, S. A., Mather, S. J., Wilkie, S. & Maher, J., Apr 2012, In: Molecular Medicine. 18, 1, p. 565-576 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Antitumor Activity 100%
  • Solid 40%
  92 Citations (Scopus)
• 2011

  Clinical investigation of the role of Interleukin-4 and Interleukin-13 in the evolution of Prostate Cancer

  Goldstein, R., Hanley, C., Morris, J., Cahill, D., Chandra, A., Harper, P., Chowdhury, S., Maher, J. & Burbridge, S., 2011, In: Cancers. 3, 4, p. 4281-4293 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Androgen 100%
  • Epithelial Cells 50%
  23 Citations (Scopus)